Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | EP300 | Q09472 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6139890 | 0.86 | PRKCA (0.36) | PTPN1EP300HIF1ACREBBP | |
| SCHEMBL2363464 | 0.79 | MEN1 (0.33) | — | |
| SCHEMBL119343 | 0.79 | MEN1 (0.33) | — | |
| SCHEMBL375499 | 0.79 | MEN1 (0.33) | — | |
| SCHEMBL6563539 | 0.78 | MEN1 (0.33) | — | |
| SCHEMBL7666136 | 0.78 | MEN1 (0.30) | — | |
| SCHEMBL4620512 | 0.77 | — | — | |
| SCHEMBL5164194 | 0.77 | MEN1 (0.32) | — | |
| SCHEMBL16457292 | 0.73 | CYP2C19 (0.38) | — | |
| SCHEMBL612164 | 0.73 | CYP2C19 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1253130-B1 | Method for producing 3-l-menthoxypropane-1,2-diol | TAKASAGO PERFUMERY CO LTD (JP) | 2005-11-02 | — | — | EP | disclosed |
| US-6515188-B2 | Reacting l-menthol with 1,2-epoxy-3-halogenopropane in an organic solvent and Lewis acid, the product is reacted with a alkali metal salt of a carboxyalkyl acid, followed by hydrolysis | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-02-04 | — | — | US | disclosed |
| EP-1253130-A2 | Method for producing 3-l-menthoxypropane-1,2-diol | Takasago International Corporation (JP) | 2002-10-30 | — | — | EP | disclosed |
| US-20020156327-A1 | Method for producing 3-l-menthoxypropane-1,2-diol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156327-A1 | Method for producing 3-l-menthoxypropane-1,2-diol | LOXL2, FAAH2, LOXL1 | PTPN1 4618/4885EP300 235/4885HIF1A 2804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.